Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia

Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia

Abstract Chronic lymphocytic leukaemia (CLL) has a highly variable clinical course. In addition to biological factors, socioeconomic factors and health system characteristics may influence CLL outcome. Data from the Brazilian Registry of CLL were analyzed to compare clinical and treatment‐related ch...

Full description

Bibliographic Details
Main Authors: Verena Pfister, Fernanda de Morais Marques, Flavia Parra, Mihoko Yamamoto, Matheus Vescovi Gonçalves, Leila Perobelli, Valeria Buccheri, Raphael Bandeira, Sergio Fortier, Alita Azevedo, Rodrigo Santucci, Marcelo Bellesso, Laura Fogliatto, Glaciano Ribeiro, Germison Silva Lopes, Maura Ikoma, Vera P. Figueiredo, Irene Gyongyver H Lorand Metze, Carlos Sérgio Chiattone, Celso Arrais‐Rodrigues
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:eJHaem
Subjects:
CLL
public health system
risk stratification
Online Access:https://doi.org/10.1002/jha2.444

Internet

https://doi.org/10.1002/jha2.444

Similar Items